Celltrion Inc.'s Remsima SC [Photo provided by Celltrion]South Korean pharmaceutical and biotech companies are pursuing strategies of changing the formulation of drugs to improve convenience for patients and to enhance their competitiveness in the global market.According to industry sources on Wednesday, a significant number of companies, including Celltrion Inc. and GC Pharma Corp., have either already changed or are in the process of changing the formulation of their pharmaceutical products.In the pharmaceutical market, where the majority of products, excluding orphan drugs, are generics, changing the formulation can improve convenience for patients and provide a differentiating factor for competition.

https://n.news.naver.com/mnews/article/009/0005154655?sid=104

#naver